Study of IgM Aggregation in Serum of Patients with Macroglobulinemia
-
Loretta Sharma
Abstract
The effect of solvent conditions on the aggregation of IgM in serum specimens from patients with macroglobulinemia was studied by a turbidimetric procedure. Aggregation of IgM varied considerably among the samples and was affected by a number of experimental parameters. In general, IgM aggregation was more pronounced under acidic conditions and in solvents with low ionic strength. The presence of watermiscible organic solvents also promoted aggregation. Based on these studies, it was concluded that the major force involved in the formation of immunoglobulin aggregates in the serum of patients with macroglobulinemia was electrostatic, rather than hydrophobic, interactions. A number of additives known to prevent protein aggregation were evaluated for their effectiveness in inhibiting IgM aggregation. The only additives that were shown to inhibit or reduce IgM aggregation were charged molecules, such as arginine, sodium chloride, ethylenediamintetraacetic acid and quaternary ammonium β-cyclodextrin. Some of these charged additives were also effective in dissociating the IgM aggregates once they were formed, even in the presence of detergent.
Copyright © 2000 by Walter de Gruyter GmbH & Co. KG
Artikel in diesem Heft
- Changes of the Coagulation and Fibrinolysis System in Malignancy: Their possible Impact on Future Diagnostic and Therapeutic Procedures
- Laboratory Support of the Clinical Nutrition Service
- A new Method for Fast Haptoglobin Phenotyping and Hemoglobin Binding Capacity Calculation Based on Capillary Zone Electrophoresis
- Apolipoprotein E Polymorphism and Serum Concentration in Alzheimer's Disease in Nine European Centres: the ApoEurope Study
- Association of the Apolipoprotein B Gene Polymorphisms with Cholesterol Levels and Response to Fluvastatin in Brazilian Individuals with High Risk for Coronary Heart Disease
- Antioxidant Status, Erythrocyte Membrane Lipid Peroxidation and Osmotic Fragility in Malignant Lymphoma Patients
- Determination of H+/K+-ATPase Activity in Human Gastric Biopsy Specimens
- European Cerebrospinal Fluid Consensus Group a TeamRoom (Lotus Notes)-Based Communication Network
- Automated Enzymatic Mitochondrial Antibody Assay for the Diagnosis of Primary Biliary Cirrhosis
- Study of IgM Aggregation in Serum of Patients with Macroglobulinemia
- Trace Element Reference Values in Serum Determined by Inductively Coupled Plasma Atomic Emission Spectrometry
- Comparison of Two Different Methods for Measurement of Phenylalanine in Dried Blood Spots
- Anti-β2-Glycoprotein I ELISA: Methodology, Determination of Cut-off Values in 434 Healthy Caucasians and Evaluation of Monoclonal Antibodies as Possible International Standards
- Comparative Multicentre Study of a Panel of Thyroid Tests Using Different Automated Immunoassay Platforms and Specimens at High Risk of Antibody Interference
- A G5569A HFE Gene Polymorphism that Interferes in DNA Tests for Genetic Haemochromatosis: Who Needs to Be Re-tested?
- Evaluation of the Conformity of Human Growth Hormone. Concentrations Measured with the DPC Immulite® and the Nichols® Advantage™ Assays
- Atlas of Atherosclerosis – Progression and Regression. By Herbert C. Stary
- Liver Disease and Laboratory Medicine. By Ian McFarlane, Adrian Bomford and Roy Sherwood
Artikel in diesem Heft
- Changes of the Coagulation and Fibrinolysis System in Malignancy: Their possible Impact on Future Diagnostic and Therapeutic Procedures
- Laboratory Support of the Clinical Nutrition Service
- A new Method for Fast Haptoglobin Phenotyping and Hemoglobin Binding Capacity Calculation Based on Capillary Zone Electrophoresis
- Apolipoprotein E Polymorphism and Serum Concentration in Alzheimer's Disease in Nine European Centres: the ApoEurope Study
- Association of the Apolipoprotein B Gene Polymorphisms with Cholesterol Levels and Response to Fluvastatin in Brazilian Individuals with High Risk for Coronary Heart Disease
- Antioxidant Status, Erythrocyte Membrane Lipid Peroxidation and Osmotic Fragility in Malignant Lymphoma Patients
- Determination of H+/K+-ATPase Activity in Human Gastric Biopsy Specimens
- European Cerebrospinal Fluid Consensus Group a TeamRoom (Lotus Notes)-Based Communication Network
- Automated Enzymatic Mitochondrial Antibody Assay for the Diagnosis of Primary Biliary Cirrhosis
- Study of IgM Aggregation in Serum of Patients with Macroglobulinemia
- Trace Element Reference Values in Serum Determined by Inductively Coupled Plasma Atomic Emission Spectrometry
- Comparison of Two Different Methods for Measurement of Phenylalanine in Dried Blood Spots
- Anti-β2-Glycoprotein I ELISA: Methodology, Determination of Cut-off Values in 434 Healthy Caucasians and Evaluation of Monoclonal Antibodies as Possible International Standards
- Comparative Multicentre Study of a Panel of Thyroid Tests Using Different Automated Immunoassay Platforms and Specimens at High Risk of Antibody Interference
- A G5569A HFE Gene Polymorphism that Interferes in DNA Tests for Genetic Haemochromatosis: Who Needs to Be Re-tested?
- Evaluation of the Conformity of Human Growth Hormone. Concentrations Measured with the DPC Immulite® and the Nichols® Advantage™ Assays
- Atlas of Atherosclerosis – Progression and Regression. By Herbert C. Stary
- Liver Disease and Laboratory Medicine. By Ian McFarlane, Adrian Bomford and Roy Sherwood
